The Tucson Myofilament Meeting is an international 3.5-day Sarver Heart Center conference that brings together approximately 250 scientists focused on the structure and function of the myofilaments that comprise the contractile machinery of muscle. Spanning topics from molecular biophysics to heart and skeletal muscle disease mechanisms and drug development, the meeting is known for its highly interactive, collaborative, and informal atmosphere, with strong engagement of early career investigators.
Traditionally held biennially at the University of Wisconsin, the meeting will continue at the University of Arizona beginning in May 2026, offering a distinctive Tucson setting that fosters scientific exchange and community building.
Department of Cellular & Molecular Medicine Seminar
Thursday, February 27, 2020 - 12:00pm to 1:00pm
Event Location:
Health Sciences Innovation Building (HSIB), Room 880
University of Arizona Health Sciences Campus
1670 E. Drachman St.
Tucson, AZ 85721
(Directions: Google Maps!)
The Department of Cellular and Molecular Medicine presents: Dr. Zhiyu Dai
SPEAKER: Zhiyu Dai, PhD
Assistant Professor, Medicine
Department of Internal Medicine
University of Arizona College of Medicine – Phoenix
“Novel Mechanisms and Targets in Pulmonary Arterial Hypertension”
Thursday, Feb. 27, 2020
Noon-1 p.m.
Health Sciences Innovation Building (HSIB), Room 880
About the presenter:
Dr. Dai received his Ph.D. from Sun Yat-sen University, China and completed his postdoctoral training in lung vascular biology at the University of Illinois at Chicago and Northwestern University. The research interest in his laboratory is studying the cellular mechanisms for severe pulmonary vascular remodeling in pulmonary hypertension and the identification of novel targets for pulmonary hypertension. The lab employs state-of-the-art technologies including genetic lineage tracing, genetic depletion, genetic reporter, and CRISPR-mediated genomic editing, AAV, single-cell RNA-sequencing as well as patient samples to study the molecular mechanisms of pulmonary vascular remodeling and identify novel therapeutics for this devastating disease. The lab is funded by NHLBI Pathway to Independence Award (Parent K99/R00) and ATS Foundation Research Program.
Seminar Announcement - Dai.pdf